This is a Ozempic news story, published by ABC News.
For more Ozempic news, you can click here:
more Ozempic newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from ABC News, you can click here:
more news from ABC NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
lower blood sugar. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest diabetes news, more insulin news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
insulinABC News
•82% Informative
Active ingredient in Ozempic , Wegovy may reduce risk of Alzheimer's disease.
Semaglutide was associated with a 70% reduced risk when compared with insulin.
About 120,000 Americans die in the U.S. each year from Alzheimer's.
VR Score
81
Informative language
79
Neutral language
81
Article tone
formal
Language
English
Language complexity
62
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links